

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.98242574 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.98242574 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.77489318 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.77489318 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.29153824 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.90678774 |
| 7 | cysteine metabolic process (GO:0006534) | 5.74755498 |
| 8 | kynurenine metabolic process (GO:0070189) | 5.72784024 |
| 9 | glyoxylate metabolic process (GO:0046487) | 5.68431938 |
| 10 | tryptophan catabolic process (GO:0006569) | 5.65859121 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 5.65859121 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 5.65859121 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.51179387 |
| 14 | alpha-linolenic acid metabolic process (GO:0036109) | 5.49516158 |
| 15 | sulfur amino acid catabolic process (GO:0000098) | 5.47722180 |
| 16 | urea cycle (GO:0000050) | 5.34597082 |
| 17 | urea metabolic process (GO:0019627) | 5.34597082 |
| 18 | tryptophan metabolic process (GO:0006568) | 5.31161790 |
| 19 | serine family amino acid catabolic process (GO:0009071) | 5.24400292 |
| 20 | lysine metabolic process (GO:0006553) | 5.22873755 |
| 21 | lysine catabolic process (GO:0006554) | 5.22873755 |
| 22 | negative regulation of fibrinolysis (GO:0051918) | 5.14383206 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 5.05169433 |
| 24 | glycine metabolic process (GO:0006544) | 4.92725578 |
| 25 | nitrogen cycle metabolic process (GO:0071941) | 4.92415206 |
| 26 | regulation of protein activation cascade (GO:2000257) | 4.91970551 |
| 27 | complement activation, alternative pathway (GO:0006957) | 4.84286060 |
| 28 | regulation of fibrinolysis (GO:0051917) | 4.83020406 |
| 29 | homocysteine metabolic process (GO:0050667) | 4.82998179 |
| 30 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.80962111 |
| 31 | protein carboxylation (GO:0018214) | 4.80962111 |
| 32 | amino-acid betaine metabolic process (GO:0006577) | 4.77223379 |
| 33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.74255035 |
| 34 | bile acid metabolic process (GO:0008206) | 4.73965222 |
| 35 | aromatic amino acid family metabolic process (GO:0009072) | 4.66636349 |
| 36 | regulation of triglyceride catabolic process (GO:0010896) | 4.64645194 |
| 37 | regulation of complement activation (GO:0030449) | 4.61288172 |
| 38 | serine family amino acid metabolic process (GO:0009069) | 4.60411084 |
| 39 | alpha-amino acid catabolic process (GO:1901606) | 4.58432291 |
| 40 | serine family amino acid biosynthetic process (GO:0009070) | 4.49702563 |
| 41 | cellular ketone body metabolic process (GO:0046950) | 4.46124040 |
| 42 | reverse cholesterol transport (GO:0043691) | 4.39068399 |
| 43 | negative regulation of cholesterol transport (GO:0032375) | 4.38430000 |
| 44 | negative regulation of sterol transport (GO:0032372) | 4.38430000 |
| 45 | tyrosine metabolic process (GO:0006570) | 4.36211162 |
| 46 | protein-lipid complex remodeling (GO:0034368) | 4.32610410 |
| 47 | macromolecular complex remodeling (GO:0034367) | 4.32610410 |
| 48 | plasma lipoprotein particle remodeling (GO:0034369) | 4.32610410 |
| 49 | regulation of cholesterol esterification (GO:0010872) | 4.28208356 |
| 50 | coenzyme catabolic process (GO:0009109) | 4.27956670 |
| 51 | cellular amino acid catabolic process (GO:0009063) | 4.27836148 |
| 52 | triglyceride homeostasis (GO:0070328) | 4.26211253 |
| 53 | acylglycerol homeostasis (GO:0055090) | 4.26211253 |
| 54 | glutamate metabolic process (GO:0006536) | 4.21761705 |
| 55 | ethanol oxidation (GO:0006069) | 4.20908879 |
| 56 | plasma lipoprotein particle clearance (GO:0034381) | 4.16738224 |
| 57 | bile acid and bile salt transport (GO:0015721) | 4.16654678 |
| 58 | phospholipid efflux (GO:0033700) | 4.04056749 |
| 59 | cellular modified amino acid catabolic process (GO:0042219) | 4.01135533 |
| 60 | proline biosynthetic process (GO:0006561) | 4.00069740 |
| 61 | acetyl-CoA metabolic process (GO:0006084) | 3.97312256 |
| 62 | indolalkylamine metabolic process (GO:0006586) | 3.95041869 |
| 63 | plasma lipoprotein particle assembly (GO:0034377) | 3.92317846 |
| 64 | aspartate family amino acid catabolic process (GO:0009068) | 3.91385852 |
| 65 | glucose 6-phosphate metabolic process (GO:0051156) | 3.90663417 |
| 66 | imidazole-containing compound metabolic process (GO:0052803) | 3.90575210 |
| 67 | benzene-containing compound metabolic process (GO:0042537) | 3.88344445 |
| 68 | ketone body metabolic process (GO:1902224) | 3.88318158 |
| 69 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.87446896 |
| 70 | drug catabolic process (GO:0042737) | 3.87208974 |
| 71 | cellular glucuronidation (GO:0052695) | 3.83686675 |
| 72 | cellular biogenic amine catabolic process (GO:0042402) | 3.83335835 |
| 73 | amine catabolic process (GO:0009310) | 3.83335835 |
| 74 | arginine metabolic process (GO:0006525) | 3.79836395 |
| 75 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.79033397 |
| 76 | short-chain fatty acid metabolic process (GO:0046459) | 3.78975739 |
| 77 | cholesterol efflux (GO:0033344) | 3.78112750 |
| 78 | organic acid catabolic process (GO:0016054) | 3.77501748 |
| 79 | carboxylic acid catabolic process (GO:0046395) | 3.77501748 |
| 80 | cofactor catabolic process (GO:0051187) | 3.76980002 |
| 81 | 2-oxoglutarate metabolic process (GO:0006103) | 3.75871176 |
| 82 | aldehyde catabolic process (GO:0046185) | 3.73749316 |
| 83 | 4-hydroxyproline metabolic process (GO:0019471) | 3.67010289 |
| 84 | proline metabolic process (GO:0006560) | 3.64024941 |
| 85 | carnitine metabolic process (GO:0009437) | 3.62766334 |
| 86 | regulation of cholesterol homeostasis (GO:2000188) | 3.62512982 |
| 87 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.62292089 |
| 88 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.62292089 |
| 89 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.61240422 |
| 90 | cholesterol homeostasis (GO:0042632) | 3.58279553 |
| 91 | fibrinolysis (GO:0042730) | 3.57366656 |
| 92 | blood coagulation, intrinsic pathway (GO:0007597) | 3.56551142 |
| 93 | positive regulation of lipid catabolic process (GO:0050996) | 3.55296817 |
| 94 | fatty acid oxidation (GO:0019395) | 3.54010349 |
| 95 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.53810455 |
| 96 | L-serine metabolic process (GO:0006563) | 3.53431332 |
| 97 | fatty acid beta-oxidation (GO:0006635) | 3.52839376 |
| 98 | protein-lipid complex assembly (GO:0065005) | 3.52232269 |
| 99 | sterol homeostasis (GO:0055092) | 3.52197781 |
| 100 | phospholipid homeostasis (GO:0055091) | 3.51237969 |
| 101 | Golgi transport vesicle coating (GO:0048200) | 3.49499958 |
| 102 | COPI coating of Golgi vesicle (GO:0048205) | 3.49499958 |
| 103 | monocarboxylic acid catabolic process (GO:0072329) | 3.49343577 |
| 104 | lipid oxidation (GO:0034440) | 3.46348027 |
| 105 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.46274172 |
| 106 | drug transmembrane transport (GO:0006855) | 3.44054692 |
| 107 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.44027303 |
| 108 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.39664680 |
| 109 | protein retention in ER lumen (GO:0006621) | 3.25711140 |
| 110 | glycolytic process (GO:0006096) | 3.08350710 |
| 111 | gluconeogenesis (GO:0006094) | 2.93880738 |
| 112 | cholesterol biosynthetic process (GO:0006695) | 2.92710811 |
| 113 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.91116993 |
| 114 | intestinal cholesterol absorption (GO:0030299) | 2.90870274 |
| 115 | daunorubicin metabolic process (GO:0044597) | 2.90173736 |
| 116 | polyketide metabolic process (GO:0030638) | 2.90173736 |
| 117 | doxorubicin metabolic process (GO:0044598) | 2.90173736 |
| 118 | * porphyrin-containing compound biosynthetic process (GO:0006779) | 2.82944365 |
| 119 | hexose biosynthetic process (GO:0019319) | 2.81944595 |
| 120 | monosaccharide biosynthetic process (GO:0046364) | 2.78463367 |
| 121 | * porphyrin-containing compound metabolic process (GO:0006778) | 2.77061348 |
| 122 | peptidyl-proline hydroxylation (GO:0019511) | 2.75811662 |
| 123 | regulation of translational fidelity (GO:0006450) | 2.75279352 |
| 124 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.56117661 |
| 125 | plasma lipoprotein particle organization (GO:0071827) | 2.51422100 |
| 126 | pyruvate metabolic process (GO:0006090) | 2.49414028 |
| 127 | lung epithelium development (GO:0060428) | 2.49338489 |
| 128 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.48578418 |
| 129 | cell migration in hindbrain (GO:0021535) | 2.46860433 |
| 130 | * tetrapyrrole biosynthetic process (GO:0033014) | 2.46750550 |
| 131 | positive regulation of mitochondrial fission (GO:0090141) | 2.46569404 |
| 132 | protein hydroxylation (GO:0018126) | 2.45944096 |
| 133 | sterol biosynthetic process (GO:0016126) | 2.45608747 |
| 134 | regulation of plasminogen activation (GO:0010755) | 2.45540236 |
| 135 | regulation of cholesterol metabolic process (GO:0090181) | 2.44543745 |
| 136 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.41459565 |
| 137 | heme biosynthetic process (GO:0006783) | 2.41129794 |
| 138 | biotin metabolic process (GO:0006768) | 2.40081090 |
| 139 | protein-lipid complex subunit organization (GO:0071825) | 2.37784069 |
| 140 | positive regulation of synapse maturation (GO:0090129) | 2.32601722 |
| 141 | heme metabolic process (GO:0042168) | 2.32501821 |
| 142 | L-serine transport (GO:0015825) | 2.31895025 |
| 143 | low-density lipoprotein particle remodeling (GO:0034374) | 2.30149608 |
| 144 | layer formation in cerebral cortex (GO:0021819) | 2.29850622 |
| 145 | cerebellar Purkinje cell layer development (GO:0021680) | 2.28401208 |
| 146 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.27912006 |
| 147 | COPII vesicle coating (GO:0048208) | 2.27578089 |
| 148 | hemoglobin metabolic process (GO:0020027) | 2.26779609 |
| 149 | basement membrane organization (GO:0071711) | 2.23371250 |
| 150 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.22926349 |
| 151 | erythrocyte maturation (GO:0043249) | 2.17457423 |
| 152 | positive regulation of nuclease activity (GO:0032075) | 2.16888895 |
| 153 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.15444831 |
| 154 | glutamine family amino acid catabolic process (GO:0009065) | 2.14671173 |
| 155 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.13476600 |
| 156 | oxygen transport (GO:0015671) | 2.11928695 |
| 157 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.10816710 |
| 158 | vesicle coating (GO:0006901) | 2.09681469 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.54142575 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.69746860 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.95560475 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.74046445 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.46389764 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.77759944 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.60554162 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.77828354 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.45777995 |
| 10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.13991693 |
| 11 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.63180193 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.35139578 |
| 13 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.34732012 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.23159455 |
| 15 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.14312238 |
| 16 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.08721510 |
| 17 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.03758858 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 2.02782013 |
| 19 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.00669842 |
| 20 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.0628242 |
| 21 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.97350850 |
| 22 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.94838776 |
| 23 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.92722913 |
| 24 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.83032831 |
| 25 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.81409981 |
| 26 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.76112701 |
| 27 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.71907960 |
| 28 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.67215232 |
| 29 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.66914536 |
| 30 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.61388267 |
| 31 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.60908585 |
| 32 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.57895257 |
| 33 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.57564644 |
| 34 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.52441940 |
| 35 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.49292357 |
| 36 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.47304850 |
| 37 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.46361105 |
| 38 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.44789412 |
| 39 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.44681618 |
| 40 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.39874520 |
| 41 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.34922666 |
| 42 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.33516502 |
| 43 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.32658789 |
| 44 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.32627660 |
| 45 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.31687912 |
| 46 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.29906236 |
| 47 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.28317910 |
| 48 | KDM2B_26808549_Chip-Seq_K562_Human | 1.26790961 |
| 49 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.25030005 |
| 50 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.24456744 |
| 51 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.24292947 |
| 52 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.23223337 |
| 53 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.22577262 |
| 54 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.19850345 |
| 55 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.19483249 |
| 56 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.18744027 |
| 57 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.17805334 |
| 58 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.15770694 |
| 59 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.13735726 |
| 60 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.13614995 |
| 61 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.13492617 |
| 62 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.12456266 |
| 63 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.10315914 |
| 64 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.10027264 |
| 65 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.08635047 |
| 66 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.08275669 |
| 67 | * TP53_22127205_ChIP-Seq_IMR90_Human | 1.07558154 |
| 68 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.07256433 |
| 69 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.06886466 |
| 70 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.05666867 |
| 71 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.05395909 |
| 72 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.05013308 |
| 73 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.04663604 |
| 74 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.03602661 |
| 75 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.02969711 |
| 76 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.02092819 |
| 77 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.01667416 |
| 78 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.01238896 |
| 79 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.00734771 |
| 80 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.00502525 |
| 81 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.99954379 |
| 82 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.99882315 |
| 83 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.98695604 |
| 84 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.97911712 |
| 85 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.97886743 |
| 86 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.97362148 |
| 87 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96889906 |
| 88 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.95535383 |
| 89 | * TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.95283171 |
| 90 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.94412812 |
| 91 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.93036028 |
| 92 | GATA1_19941826_ChIP-Seq_K562_Human | 0.92220012 |
| 93 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.92147506 |
| 94 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.90933555 |
| 95 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.84590021 |
| 96 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.84154767 |
| 97 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.83364398 |
| 98 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.80402610 |
| 99 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.78222041 |
| 100 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.77713170 |
| 101 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.77675657 |
| 102 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.74350705 |
| 103 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.72944872 |
| 104 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.72570437 |
| 105 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.71196244 |
| 106 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.70887305 |
| 107 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.70320208 |
| 108 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.69856654 |
| 109 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.69434738 |
| 110 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.68489870 |
| 111 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.68059016 |
| 112 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.67096389 |
| 113 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.66719955 |
| 114 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.66345726 |
| 115 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.65736798 |
| 116 | P68_20966046_ChIP-Seq_HELA_Human | 0.64963732 |
| 117 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.64100664 |
| 118 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.64003267 |
| 119 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.62161579 |
| 120 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.62006897 |
| 121 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.60477767 |
| 122 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.59441980 |
| 123 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.59002787 |
| 124 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.58692474 |
| 125 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.57490038 |
| 126 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.57365622 |
| 127 | GATA2_19941826_ChIP-Seq_K562_Human | 0.57281998 |
| 128 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.56007175 |
| 129 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.55793864 |
| 130 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.55368667 |
| 131 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.55317119 |
| 132 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.54808568 |
| 133 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.54675269 |
| 134 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.54673944 |
| 135 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.54526351 |
| 136 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.53873679 |
| 137 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.53693270 |
| 138 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.53329090 |
| 139 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.53131188 |
| 140 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.52740648 |
| 141 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.52688157 |
| 142 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.52244502 |
| 143 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.52039874 |
| 144 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.51909570 |
| 145 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.51816000 |
| 146 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.51185145 |
| 147 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.51138995 |
| 148 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.50883955 |
| 149 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.49836410 |
| 150 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.49686210 |
| 151 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.49124556 |
| 152 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.48880022 |
| 153 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 0.48832751 |
| 154 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.47667833 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.03192716 |
| 2 | MP0005360_urolithiasis | 7.26615694 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.14758197 |
| 4 | MP0005365_abnormal_bile_salt | 5.87288544 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.79418753 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.45388028 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.50398641 |
| 8 | MP0003252_abnormal_bile_duct | 3.48285672 |
| 9 | MP0005083_abnormal_biliary_tract | 3.47126239 |
| 10 | MP0009840_abnormal_foam_cell | 3.42359469 |
| 11 | MP0003122_maternal_imprinting | 2.99863853 |
| 12 | MP0005332_abnormal_amino_acid | 2.82310116 |
| 13 | MP0003656_abnormal_erythrocyte_physiolo | 2.71633033 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.69932578 |
| 15 | MP0003195_calcinosis | 2.46493376 |
| 16 | MP0001529_abnormal_vocalization | 2.27742796 |
| 17 | MP0004859_abnormal_synaptic_plasticity | 2.18689562 |
| 18 | MP0000609_abnormal_liver_physiology | 2.17550002 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 2.10884331 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 2.09633240 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 2.06812806 |
| 22 | MP0004270_analgesia | 1.97172542 |
| 23 | MP0005319_abnormal_enzyme/_coenzyme | 1.92023964 |
| 24 | MP0008260_abnormal_autophagy | 1.89721867 |
| 25 | MP0000566_synostosis | 1.78606393 |
| 26 | MP0004272_abnormal_basement_membrane | 1.76488188 |
| 27 | MP0003136_yellow_coat_color | 1.76174555 |
| 28 | MP0008438_abnormal_cutaneous_collagen | 1.73969111 |
| 29 | MP0003868_abnormal_feces_composition | 1.72610215 |
| 30 | MP0004858_abnormal_nervous_system | 1.69539902 |
| 31 | MP0001764_abnormal_homeostasis | 1.69274614 |
| 32 | MP0003123_paternal_imprinting | 1.68437309 |
| 33 | MP0004233_abnormal_muscle_weight | 1.65991221 |
| 34 | MP0003879_abnormal_hair_cell | 1.64236400 |
| 35 | MP0003705_abnormal_hypodermis_morpholog | 1.54542960 |
| 36 | MP0002138_abnormal_hepatobiliary_system | 1.53731652 |
| 37 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.53562057 |
| 38 | MP0009780_abnormal_chondrocyte_physiolo | 1.49972866 |
| 39 | MP0003186_abnormal_redox_activity | 1.46451579 |
| 40 | MP0009643_abnormal_urine_homeostasis | 1.40658177 |
| 41 | MP0005451_abnormal_body_composition | 1.40486618 |
| 42 | MP0006036_abnormal_mitochondrial_physio | 1.40472603 |
| 43 | MP0004147_increased_porphyrin_level | 1.40014786 |
| 44 | MP0003942_abnormal_urinary_system | 1.36006340 |
| 45 | MP0003878_abnormal_ear_physiology | 1.32360862 |
| 46 | MP0005377_hearing/vestibular/ear_phenot | 1.32360862 |
| 47 | MP0005171_absent_coat_pigmentation | 1.26255098 |
| 48 | MP0002089_abnormal_postnatal_growth/wei | 1.25266443 |
| 49 | MP0005499_abnormal_olfactory_system | 1.24705121 |
| 50 | MP0005394_taste/olfaction_phenotype | 1.24705121 |
| 51 | MP0000598_abnormal_liver_morphology | 1.23336681 |
| 52 | MP0003011_delayed_dark_adaptation | 1.23308510 |
| 53 | MP0005636_abnormal_mineral_homeostasis | 1.22423106 |
| 54 | MP0005670_abnormal_white_adipose | 1.17819859 |
| 55 | MP0003385_abnormal_body_wall | 1.12352755 |
| 56 | MP0005257_abnormal_intraocular_pressure | 1.12052931 |
| 57 | MP0000751_myopathy | 1.11161574 |
| 58 | MP0010030_abnormal_orbit_morphology | 1.09892931 |
| 59 | MP0008932_abnormal_embryonic_tissue | 1.07555474 |
| 60 | MP0003111_abnormal_nucleus_morphology | 1.07362180 |
| 61 | MP0000955_abnormal_spinal_cord | 1.06676667 |
| 62 | MP0009697_abnormal_copulation | 1.06608607 |
| 63 | MP0001984_abnormal_olfaction | 1.03356872 |
| 64 | MP0004130_abnormal_muscle_cell | 0.99248320 |
| 65 | MP0002909_abnormal_adrenal_gland | 0.97527342 |
| 66 | MP0001661_extended_life_span | 0.97090829 |
| 67 | MP0000604_amyloidosis | 0.96896185 |
| 68 | MP0005647_abnormal_sex_gland | 0.96482899 |
| 69 | MP0003890_abnormal_embryonic-extraembry | 0.95949904 |
| 70 | MP0006035_abnormal_mitochondrial_morpho | 0.95866382 |
| 71 | MP0001299_abnormal_eye_distance/ | 0.95553865 |
| 72 | MP0002837_dystrophic_cardiac_calcinosis | 0.95518981 |
| 73 | MP0003941_abnormal_skin_development | 0.95350385 |
| 74 | MP0004133_heterotaxia | 0.94685684 |
| 75 | MP0002697_abnormal_eye_size | 0.94333329 |
| 76 | MP0006276_abnormal_autonomic_nervous | 0.93060088 |
| 77 | MP0000749_muscle_degeneration | 0.91703371 |
| 78 | MP0005423_abnormal_somatic_nervous | 0.91519917 |
| 79 | MP0000003_abnormal_adipose_tissue | 0.87123135 |
| 80 | MP0001756_abnormal_urination | 0.86830930 |
| 81 | MP0005076_abnormal_cell_differentiation | 0.86141688 |
| 82 | MP0001915_intracranial_hemorrhage | 0.85148254 |
| 83 | MP0002249_abnormal_larynx_morphology | 0.84763432 |
| 84 | MP0009763_increased_sensitivity_to | 0.84073289 |
| 85 | MP0009642_abnormal_blood_homeostasis | 0.83978868 |
| 86 | MP0003567_abnormal_fetal_cardiomyocyte | 0.83814522 |
| 87 | MP0003566_abnormal_cell_adhesion | 0.83643673 |
| 88 | MP0009053_abnormal_anal_canal | 0.83432127 |
| 89 | MP0003861_abnormal_nervous_system | 0.81396877 |
| 90 | MP0004087_abnormal_muscle_fiber | 0.81127122 |
| 91 | MP0002078_abnormal_glucose_homeostasis | 0.81036030 |
| 92 | MP0005266_abnormal_metabolism | 0.80879494 |
| 93 | MP0004145_abnormal_muscle_electrophysio | 0.80367058 |
| 94 | MP0005376_homeostasis/metabolism_phenot | 0.80246050 |
| 95 | MP0002971_abnormal_brown_adipose | 0.79895972 |
| 96 | MP0002152_abnormal_brain_morphology | 0.79325152 |
| 97 | MP0004811_abnormal_neuron_physiology | 0.78969934 |
| 98 | MP0002638_abnormal_pupillary_reflex | 0.78508715 |
| 99 | MP0002822_catalepsy | 0.77726049 |
| 100 | MP0003115_abnormal_respiratory_system | 0.77056776 |
| 101 | MP0003121_genomic_imprinting | 0.74404467 |
| 102 | MP0002092_abnormal_eye_morphology | 0.74286789 |
| 103 | MP0008789_abnormal_olfactory_epithelium | 0.74219130 |
| 104 | MP0003329_amyloid_beta_deposits | 0.73993241 |
| 105 | MP0003635_abnormal_synaptic_transmissio | 0.73744692 |
| 106 | MP0000778_abnormal_nervous_system | 0.73687865 |
| 107 | MP0003718_maternal_effect | 0.73372646 |
| 108 | MP0002734_abnormal_mechanical_nocicepti | 0.73361914 |
| 109 | MP0002080_prenatal_lethality | 0.72707488 |
| 110 | MP0002269_muscular_atrophy | 0.72671825 |
| 111 | MP0005220_abnormal_exocrine_pancreas | 0.72071025 |
| 112 | MP0000049_abnormal_middle_ear | 0.71636248 |
| 113 | MP0009764_decreased_sensitivity_to | 0.71211617 |
| 114 | MP0008469_abnormal_protein_level | 0.70617715 |
| 115 | MP0002882_abnormal_neuron_morphology | 0.70111193 |
| 116 | MP0000534_abnormal_ureter_morphology | 0.70055003 |
| 117 | MP0002233_abnormal_nose_morphology | 0.69898667 |
| 118 | MP0001270_distended_abdomen | 0.69847691 |
| 119 | MP0001697_abnormal_embryo_size | 0.68885165 |
| 120 | MP0005408_hypopigmentation | 0.68687204 |
| 121 | MP0003315_abnormal_perineum_morphology | 0.68170262 |
| 122 | MP0005334_abnormal_fat_pad | 0.67355483 |
| 123 | MP0005666_abnormal_adipose_tissue | 0.67310157 |
| 124 | MP0009765_abnormal_xenobiotic_induced | 0.67306997 |
| 125 | MP0001672_abnormal_embryogenesis/_devel | 0.65022226 |
| 126 | MP0005380_embryogenesis_phenotype | 0.65022226 |
| 127 | MP0002653_abnormal_ependyma_morphology | 0.64981553 |
| 128 | MP0005535_abnormal_body_temperature | 0.64360663 |
| 129 | MP0009672_abnormal_birth_weight | 0.55693213 |
| 130 | MP0008872_abnormal_physiological_respon | 0.54437015 |
| 131 | MP0002876_abnormal_thyroid_physiology | 0.53275554 |
| 132 | MP0005448_abnormal_energy_balance | 0.52744858 |
| 133 | MP0005084_abnormal_gallbladder_morpholo | 0.52077363 |
| 134 | MP0002136_abnormal_kidney_physiology | 0.51670363 |
| 135 | MP0002970_abnormal_white_adipose | 0.49945590 |
| 136 | MP0003646_muscle_fatigue | 0.48243082 |
| 137 | MP0008873_increased_physiological_sensi | 0.48000319 |
| 138 | MP0005330_cardiomyopathy | 0.47928244 |
| 139 | MP0005395_other_phenotype | 0.46209360 |
| 140 | MP0010368_abnormal_lymphatic_system | 0.43915919 |
| 141 | MP0003953_abnormal_hormone_level | 0.43582612 |
| 142 | MP0003221_abnormal_cardiomyocyte_apopto | 0.42261877 |
| 143 | MP0005187_abnormal_penis_morphology | 0.42241521 |
| 144 | MP0004264_abnormal_extraembryonic_tissu | 0.41413480 |
| 145 | MP0000747_muscle_weakness | 0.40629133 |
| 146 | MP0005058_abnormal_lysosome_morphology | 0.40470137 |
| 147 | MP0004043_abnormal_pH_regulation | 0.40373816 |
| 148 | MP0003690_abnormal_glial_cell | 0.39964839 |
| 149 | MP0004185_abnormal_adipocyte_glucose | 0.39485623 |
| 150 | MP0000639_abnormal_adrenal_gland | 0.35973459 |
| 151 | MP0009115_abnormal_fat_cell | 0.35972694 |
| 152 | MP0002254_reproductive_system_inflammat | 0.34967381 |
| 153 | MP0003638_abnormal_response/metabolism_ | 0.33612732 |
| 154 | MP0001243_abnormal_dermal_layer | 0.33512635 |
| 155 | MP0002796_impaired_skin_barrier | 0.32855615 |
| 156 | MP0008874_decreased_physiological_sensi | 0.31589381 |
| 157 | MP0000358_abnormal_cell_content/ | 0.30993892 |
| 158 | MP0005464_abnormal_platelet_physiology | 0.30570781 |
| 159 | MP0000230_abnormal_systemic_arterial | 0.28337613 |
| 160 | MP0002135_abnormal_kidney_morphology | 0.27550110 |
| 161 | MP0005375_adipose_tissue_phenotype | 0.26752300 |
| 162 | MP0003699_abnormal_female_reproductive | 0.26655498 |
| 163 | MP0005452_abnormal_adipose_tissue | 0.25694104 |
| 164 | MP0002132_abnormal_respiratory_system | 0.24312795 |
| 165 | MP0010234_abnormal_vibrissa_follicle | 0.22521267 |
| 166 | MP0002090_abnormal_vision | 0.21548475 |
| 167 | MP0001730_embryonic_growth_arrest | 0.20903657 |
| 168 | MP0005248_abnormal_Harderian_gland | 0.20794190 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.61028744 |
| 2 | Deep venous thrombosis (HP:0002625) | 6.58147276 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 6.43661762 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.13377896 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 5.98995951 |
| 6 | Xanthomatosis (HP:0000991) | 5.90145986 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.31216734 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.09782226 |
| 9 | Hyperammonemia (HP:0001987) | 4.65683520 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.61642827 |
| 11 | Complement deficiency (HP:0004431) | 4.58122952 |
| 12 | Hyperglycinemia (HP:0002154) | 4.56556623 |
| 13 | Ketosis (HP:0001946) | 4.40951114 |
| 14 | Hyperglycinuria (HP:0003108) | 4.33118841 |
| 15 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.24451081 |
| 16 | Abnormality of glycine metabolism (HP:0010895) | 4.22157872 |
| 17 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.22157872 |
| 18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.14459311 |
| 19 | Hypoalphalipoproteinemia (HP:0003233) | 4.09800732 |
| 20 | Abnormality of methionine metabolism (HP:0010901) | 3.96921915 |
| 21 | Epidermoid cyst (HP:0200040) | 3.94283459 |
| 22 | Hypoglycemic coma (HP:0001325) | 3.92417507 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.92360775 |
| 24 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.91058215 |
| 25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.87812163 |
| 26 | Joint hemorrhage (HP:0005261) | 3.78306404 |
| 27 | Hyperbilirubinemia (HP:0002904) | 3.72808640 |
| 28 | Abnormality of the common coagulation pathway (HP:0010990) | 3.70138867 |
| 29 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.67538792 |
| 30 | Fat malabsorption (HP:0002630) | 3.64465386 |
| 31 | Abnormality of reticulocytes (HP:0004312) | 3.62829010 |
| 32 | Abnormality of glycolysis (HP:0004366) | 3.60514277 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.48238320 |
| 34 | Poikilocytosis (HP:0004447) | 3.48165091 |
| 35 | Acanthocytosis (HP:0001927) | 3.37412914 |
| 36 | Hypochromic microcytic anemia (HP:0004840) | 3.36492210 |
| 37 | Abnormality of complement system (HP:0005339) | 3.34611533 |
| 38 | Ketoacidosis (HP:0001993) | 3.25800108 |
| 39 | Abnormality of the intrinsic pathway (HP:0010989) | 3.24629150 |
| 40 | Cholelithiasis (HP:0001081) | 3.24389677 |
| 41 | Abnormality of serum amino acid levels (HP:0003112) | 3.23217234 |
| 42 | Abnormal gallbladder morphology (HP:0012437) | 3.15510013 |
| 43 | Abnormality of nucleobase metabolism (HP:0010932) | 3.14639650 |
| 44 | Hypercholesterolemia (HP:0003124) | 3.13646365 |
| 45 | Hepatocellular carcinoma (HP:0001402) | 3.08116694 |
| 46 | Gout (HP:0001997) | 3.03459995 |
| 47 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.02561675 |
| 48 | Dicarboxylic aciduria (HP:0003215) | 3.02561675 |
| 49 | Metabolic acidosis (HP:0001942) | 2.97131847 |
| 50 | Increased serum pyruvate (HP:0003542) | 2.94035977 |
| 51 | Delayed CNS myelination (HP:0002188) | 2.93175878 |
| 52 | Cholecystitis (HP:0001082) | 2.92870897 |
| 53 | Abnormal gallbladder physiology (HP:0012438) | 2.92870897 |
| 54 | Reticulocytosis (HP:0001923) | 2.90934176 |
| 55 | Conjugated hyperbilirubinemia (HP:0002908) | 2.87650434 |
| 56 | Lethargy (HP:0001254) | 2.87273052 |
| 57 | Abnormality of purine metabolism (HP:0004352) | 2.76430368 |
| 58 | Exercise-induced muscle cramps (HP:0003710) | 2.74821024 |
| 59 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.74191428 |
| 60 | Steatorrhea (HP:0002570) | 2.71270583 |
| 61 | Skin nodule (HP:0200036) | 2.70445208 |
| 62 | Cerebral edema (HP:0002181) | 2.66928845 |
| 63 | Spastic diplegia (HP:0001264) | 2.65241420 |
| 64 | Myocardial infarction (HP:0001658) | 2.49817332 |
| 65 | Abnormality of the gallbladder (HP:0005264) | 2.46320999 |
| 66 | Brushfield spots (HP:0001088) | 2.43522496 |
| 67 | Small epiphyses (HP:0010585) | 2.42596624 |
| 68 | Spontaneous abortion (HP:0005268) | 2.39485868 |
| 69 | Malnutrition (HP:0004395) | 2.35455213 |
| 70 | Irritability (HP:0000737) | 2.34229806 |
| 71 | Vomiting (HP:0002013) | 2.32536780 |
| 72 | Mitral stenosis (HP:0001718) | 2.31544582 |
| 73 | Neonatal onset (HP:0003623) | 2.26301841 |
| 74 | Insomnia (HP:0100785) | 2.23008488 |
| 75 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.21795797 |
| 76 | Hypoglycemic seizures (HP:0002173) | 2.19526187 |
| 77 | Vascular calcification (HP:0004934) | 2.17131287 |
| 78 | Abnormality of the Achilles tendon (HP:0005109) | 2.17034121 |
| 79 | Generalized aminoaciduria (HP:0002909) | 2.16518589 |
| 80 | Systemic lupus erythematosus (HP:0002725) | 2.15785063 |
| 81 | Nausea (HP:0002018) | 2.15664973 |
| 82 | Hammertoe (HP:0001765) | 2.15288608 |
| 83 | Impaired pain sensation (HP:0007328) | 2.14319615 |
| 84 | Abnormality of pain sensation (HP:0010832) | 2.14319615 |
| 85 | Abnormal tarsal ossification (HP:0008369) | 2.13581611 |
| 86 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.13283318 |
| 87 | Abnormality of iron homeostasis (HP:0011031) | 2.12283337 |
| 88 | Pterygium (HP:0001059) | 2.08838493 |
| 89 | Sensorimotor neuropathy (HP:0007141) | 2.07791138 |
| 90 | Polycythemia (HP:0001901) | 2.07186561 |
| 91 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.06710511 |
| 92 | Late onset (HP:0003584) | 2.06438397 |
| 93 | Abnormal cartilage morphology (HP:0002763) | 2.05248700 |
| 94 | Increased purine levels (HP:0004368) | 2.02148355 |
| 95 | Hyperuricemia (HP:0002149) | 2.02148355 |
| 96 | Hand muscle atrophy (HP:0009130) | 2.01036013 |
| 97 | Global brain atrophy (HP:0002283) | 1.98069150 |
| 98 | Hemorrhage of the eye (HP:0011885) | 1.97908142 |
| 99 | Broad alveolar ridges (HP:0000187) | 1.97755911 |
| 100 | Pancreatitis (HP:0001733) | 1.97740323 |
| 101 | Premature rupture of membranes (HP:0001788) | 1.97228564 |
| 102 | Diaphragmatic weakness (HP:0009113) | 1.94562094 |
| 103 | Distal upper limb amyotrophy (HP:0007149) | 1.91928346 |
| 104 | Upper limb amyotrophy (HP:0009129) | 1.91928346 |
| 105 | Cardiovascular calcification (HP:0011915) | 1.91346799 |
| 106 | Esophageal varix (HP:0002040) | 1.91217977 |
| 107 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.91152193 |
| 108 | Abnormality of carpal bone ossification (HP:0006257) | 1.90414540 |
| 109 | Proximal tubulopathy (HP:0000114) | 1.90231999 |
| 110 | Myoglobinuria (HP:0002913) | 1.87742995 |
| 111 | Opisthotonus (HP:0002179) | 1.86237632 |
| 112 | Glomerulonephritis (HP:0000099) | 1.85758581 |
| 113 | Hyperglycemia (HP:0003074) | 1.85313973 |
| 114 | Increased serum ferritin (HP:0003281) | 1.84978193 |
| 115 | Myopathic facies (HP:0002058) | 1.84660374 |
| 116 | Ulnar bowing (HP:0003031) | 1.83674316 |
| 117 | Rickets (HP:0002748) | 1.82678421 |
| 118 | Status epilepticus (HP:0002133) | 1.82416015 |
| 119 | Back pain (HP:0003418) | 1.80702339 |
| 120 | Enlarged kidneys (HP:0000105) | 1.80490513 |
| 121 | Abnormality of dentin (HP:0010299) | 1.80094198 |
| 122 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.79602709 |
| 123 | Absent epiphyses (HP:0010577) | 1.79602709 |
| 124 | Breech presentation (HP:0001623) | 1.79166033 |
| 125 | Hyperthyroidism (HP:0000836) | 1.78507626 |
| 126 | Ileus (HP:0002595) | 1.78476862 |
| 127 | Protrusio acetabuli (HP:0003179) | 1.78360775 |
| 128 | Thrombophlebitis (HP:0004418) | 1.77490662 |
| 129 | Abnormality of vitamin metabolism (HP:0100508) | 1.76438289 |
| 130 | Overlapping toe (HP:0001845) | 1.76203175 |
| 131 | Exercise-induced myalgia (HP:0003738) | 1.75548581 |
| 132 | Osteomalacia (HP:0002749) | 1.73805017 |
| 133 | Abnormal delivery (HP:0001787) | 1.71945746 |
| 134 | Achilles tendon contracture (HP:0001771) | 1.70319126 |
| 135 | Myokymia (HP:0002411) | 1.66716479 |
| 136 | Upper limb muscle weakness (HP:0003484) | 1.64063169 |
| 137 | Nuclear cataract (HP:0100018) | 1.61645490 |
| 138 | Termporal pattern (HP:0011008) | 1.60404504 |
| 139 | Insidious onset (HP:0003587) | 1.60404504 |
| 140 | Paralysis (HP:0003470) | 1.58883754 |
| 141 | Peripheral hypomyelination (HP:0007182) | 1.58056585 |
| 142 | Bronchomalacia (HP:0002780) | 1.54668518 |
| 143 | Broad palm (HP:0001169) | 1.52982502 |
| 144 | Atelectasis (HP:0100750) | 1.52584050 |
| 145 | Asymmetry of the thorax (HP:0001555) | 1.52404067 |
| 146 | Hypoparathyroidism (HP:0000829) | 1.52182284 |
| 147 | Shallow orbits (HP:0000586) | 1.51618311 |
| 148 | Alacrima (HP:0000522) | 1.50712550 |
| 149 | Decreased motor nerve conduction velocity (HP:0003431) | 1.50495086 |
| 150 | Coronal craniosynostosis (HP:0004440) | 1.49413517 |
| 151 | Menorrhagia (HP:0000132) | 1.49116130 |
| 152 | Cortical dysplasia (HP:0002539) | 1.49054194 |
| 153 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.48043123 |
| 154 | Myelomeningocele (HP:0002475) | 1.46096068 |
| 155 | Rhabdomyolysis (HP:0003201) | 1.44887480 |
| 156 | Foot dorsiflexor weakness (HP:0009027) | 1.43005891 |
| 157 | Hyperacusis (HP:0010780) | 1.42469670 |
| 158 | Abnormal ossification of hand bones (HP:0005921) | 1.41999565 |
| 159 | Abnormality of the calcaneus (HP:0008364) | 1.41339254 |
| 160 | Abnormal hemoglobin (HP:0011902) | 1.41247082 |
| 161 | Heterotopia (HP:0002282) | 1.40701407 |
| 162 | Truncus arteriosus (HP:0001660) | 1.40372680 |
| 163 | Hepatoblastoma (HP:0002884) | 1.40291929 |
| 164 | Abnormality of the aortic arch (HP:0012303) | 1.39688233 |
| 165 | Vertebral compression fractures (HP:0002953) | 1.38982112 |
| 166 | Neonatal death (HP:0003811) | 1.37819932 |
| 167 | Turricephaly (HP:0000262) | 1.34026875 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.10333693 |
| 2 | ERN1 | 3.62747296 |
| 3 | SIK1 | 3.61737840 |
| 4 | TRIB3 | 3.12978241 |
| 5 | FGFR4 | 2.96532123 |
| 6 | PKN2 | 2.74082765 |
| 7 | PDK4 | 2.50261870 |
| 8 | PDK3 | 2.50261870 |
| 9 | NEK1 | 2.46539867 |
| 10 | EIF2AK1 | 2.30923709 |
| 11 | ERBB4 | 2.27468321 |
| 12 | MST1R | 2.14221285 |
| 13 | PRKD3 | 2.09851790 |
| 14 | MAP2K4 | 1.85203783 |
| 15 | CDK12 | 1.82488132 |
| 16 | PBK | 1.77557017 |
| 17 | MAPK11 | 1.75676015 |
| 18 | TAOK3 | 1.72067950 |
| 19 | MARK1 | 1.71888385 |
| 20 | BUB1 | 1.70684228 |
| 21 | SIK2 | 1.69200740 |
| 22 | PIM2 | 1.58381570 |
| 23 | FLT3 | 1.55465466 |
| 24 | ABL2 | 1.46529897 |
| 25 | DAPK2 | 1.44005714 |
| 26 | SMG1 | 1.43646858 |
| 27 | MAP3K10 | 1.36889900 |
| 28 | NME1 | 1.36769881 |
| 29 | MAPKAPK3 | 1.35542156 |
| 30 | LATS1 | 1.31364446 |
| 31 | ICK | 1.28793331 |
| 32 | GRK6 | 1.21929104 |
| 33 | ARAF | 1.21251981 |
| 34 | PINK1 | 1.15264657 |
| 35 | NTRK2 | 1.14768806 |
| 36 | PDK2 | 1.14449439 |
| 37 | TYRO3 | 1.14139601 |
| 38 | WEE1 | 1.13809358 |
| 39 | PTK6 | 1.10905188 |
| 40 | BCR | 1.10415933 |
| 41 | MAP2K3 | 1.05720998 |
| 42 | PHKG2 | 1.05338877 |
| 43 | PHKG1 | 1.05338877 |
| 44 | NEK2 | 1.05295153 |
| 45 | KDR | 1.04540753 |
| 46 | CDK4 | 1.03310593 |
| 47 | INSRR | 1.02442280 |
| 48 | CAMK1G | 0.99373326 |
| 49 | ERBB2 | 0.98070284 |
| 50 | MAP3K11 | 0.97145453 |
| 51 | MET | 0.95341873 |
| 52 | EPHA2 | 0.95272173 |
| 53 | MAP3K9 | 0.94560564 |
| 54 | MAP2K2 | 0.94061528 |
| 55 | SCYL2 | 0.93656358 |
| 56 | CDK6 | 0.91670899 |
| 57 | PRKAA1 | 0.90488223 |
| 58 | CDK7 | 0.90443914 |
| 59 | PIK3CG | 0.89417993 |
| 60 | DYRK2 | 0.85969916 |
| 61 | JAK2 | 0.85699506 |
| 62 | EPHA3 | 0.85003325 |
| 63 | IRAK3 | 0.84348349 |
| 64 | CAMK1D | 0.83193055 |
| 65 | BRSK1 | 0.83069720 |
| 66 | TTK | 0.82123721 |
| 67 | MAP3K8 | 0.80709565 |
| 68 | NME2 | 0.80505354 |
| 69 | PAK6 | 0.80252214 |
| 70 | NEK9 | 0.79254111 |
| 71 | PRKAA2 | 0.79226644 |
| 72 | MAP2K1 | 0.78955507 |
| 73 | MTOR | 0.76220601 |
| 74 | STK38 | 0.75287722 |
| 75 | CDK15 | 0.74838540 |
| 76 | CDK14 | 0.73131326 |
| 77 | TSSK6 | 0.72653606 |
| 78 | EEF2K | 0.72443375 |
| 79 | MAPKAPK5 | 0.72361199 |
| 80 | AURKA | 0.71986147 |
| 81 | CDK11A | 0.71297872 |
| 82 | CDK18 | 0.71133044 |
| 83 | SRPK1 | 0.69717042 |
| 84 | RIPK1 | 0.69266887 |
| 85 | EPHB2 | 0.69186386 |
| 86 | DYRK1B | 0.68833140 |
| 87 | LATS2 | 0.67808633 |
| 88 | TYK2 | 0.65874810 |
| 89 | PRKCZ | 0.65403992 |
| 90 | PRKACG | 0.64910853 |
| 91 | PLK2 | 0.64892912 |
| 92 | CDC7 | 0.64571186 |
| 93 | MAPK12 | 0.64203645 |
| 94 | TESK2 | 0.63822389 |
| 95 | KSR2 | 0.63053398 |
| 96 | TTN | 0.62519066 |
| 97 | TAOK1 | 0.61792927 |
| 98 | CAMK2B | 0.60898361 |
| 99 | MAP3K3 | 0.60476925 |
| 100 | MARK2 | 0.59897658 |
| 101 | CSNK1G2 | 0.58132898 |
| 102 | BRSK2 | 0.57575019 |
| 103 | PTK2 | 0.57109844 |
| 104 | LMTK2 | 0.55501180 |
| 105 | PRKCI | 0.53922507 |
| 106 | RPS6KB2 | 0.53741149 |
| 107 | MAP2K7 | 0.53548530 |
| 108 | ACVR1B | 0.53397927 |
| 109 | MAP3K5 | 0.53220858 |
| 110 | STK4 | 0.52696233 |
| 111 | NTRK3 | 0.52500528 |
| 112 | GSK3A | 0.51288141 |
| 113 | FGFR1 | 0.50879193 |
| 114 | EIF2AK3 | 0.50431049 |
| 115 | MAP3K7 | 0.50352136 |
| 116 | BRAF | 0.50053317 |
| 117 | EPHA4 | 0.48695779 |
| 118 | AKT2 | 0.48532109 |
| 119 | MINK1 | 0.48089507 |
| 120 | CSNK1G3 | 0.47717267 |
| 121 | PDPK1 | 0.47698875 |
| 122 | MAPK4 | 0.46694187 |
| 123 | DYRK3 | 0.45662449 |
| 124 | UHMK1 | 0.45468314 |
| 125 | CDK1 | 0.45406499 |
| 126 | MAP2K6 | 0.44267517 |
| 127 | PDGFRA | 0.43961564 |
| 128 | FGFR3 | 0.43863753 |
| 129 | WNK1 | 0.43739421 |
| 130 | SGK223 | 0.42904966 |
| 131 | SGK494 | 0.42904966 |
| 132 | FER | 0.42699587 |
| 133 | OBSCN | 0.41439933 |
| 134 | WNK3 | 0.41082881 |
| 135 | TLK1 | 0.40632576 |
| 136 | MAP3K6 | 0.40480995 |
| 137 | CDK5 | 0.40157919 |
| 138 | WNK4 | 0.39975735 |
| 139 | MAPK10 | 0.39894006 |
| 140 | PLK1 | 0.36722372 |
| 141 | STK38L | 0.36033299 |
| 142 | CAMK2G | 0.35113539 |
| 143 | RET | 0.34961915 |
| 144 | STK3 | 0.32257065 |
| 145 | PDK1 | 0.29002010 |
| 146 | AURKB | 0.27937630 |
| 147 | RPS6KA1 | 0.27569242 |
| 148 | SGK3 | 0.27285506 |
| 149 | BMX | 0.25824044 |
| 150 | CSNK1E | 0.25735869 |
| 151 | NTRK1 | 0.25437589 |
| 152 | STK16 | 0.25425479 |
| 153 | PRKCG | 0.25189019 |
| 154 | PIK3CA | 0.22536397 |
| 155 | CAMKK1 | 0.22141669 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.03128287 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.34302013 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.24078818 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.14292285 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.88979595 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.87024222 |
| 7 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.67288939 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.59364646 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.56914345 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.49398990 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.47149830 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.29787888 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.20629922 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.18439479 |
| 15 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.06397198 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.05965042 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 1.95153465 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.90128599 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.89232567 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85269955 |
| 21 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.75243861 |
| 22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.75109729 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.74466071 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.72931874 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.71799091 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.70741222 |
| 27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.69021125 |
| 28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.68347634 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65056625 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.56996970 |
| 31 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.56726052 |
| 32 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.54419123 |
| 33 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.53934162 |
| 34 | Carbon metabolism_Homo sapiens_hsa01200 | 1.53721983 |
| 35 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.53656965 |
| 36 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.51848989 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.50920989 |
| 38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.50915614 |
| 39 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.48670930 |
| 40 | Retinol metabolism_Homo sapiens_hsa00830 | 1.47128595 |
| 41 | Bile secretion_Homo sapiens_hsa04976 | 1.44731771 |
| 42 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.39938793 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.38068015 |
| 44 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.35257395 |
| 45 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.31707093 |
| 46 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.25495207 |
| 47 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.22962794 |
| 48 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.22452303 |
| 49 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.19221643 |
| 50 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.16715105 |
| 51 | Sulfur relay system_Homo sapiens_hsa04122 | 1.16297913 |
| 52 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.09954186 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.04255019 |
| 54 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.02797618 |
| 55 | * ABC transporters_Homo sapiens_hsa02010 | 1.02442812 |
| 56 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.98228287 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.91975999 |
| 58 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.91346271 |
| 59 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.90898255 |
| 60 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.87474245 |
| 61 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.87235098 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.86501421 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.84794179 |
| 64 | Lysine degradation_Homo sapiens_hsa00310 | 0.81244138 |
| 65 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.77528855 |
| 66 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.77430158 |
| 67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.72669826 |
| 68 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.70519881 |
| 69 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.62327222 |
| 70 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.61217015 |
| 71 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.56219341 |
| 72 | Metabolic pathways_Homo sapiens_hsa01100 | 0.55658088 |
| 73 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.54327286 |
| 74 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.54193036 |
| 75 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.53931013 |
| 76 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.51296822 |
| 77 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.50825337 |
| 78 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44829304 |
| 79 | Galactose metabolism_Homo sapiens_hsa00052 | 0.42370693 |
| 80 | Thyroid cancer_Homo sapiens_hsa05216 | 0.42066912 |
| 81 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.41252098 |
| 82 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.40996181 |
| 83 | Axon guidance_Homo sapiens_hsa04360 | 0.38635902 |
| 84 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.38106591 |
| 85 | Nicotine addiction_Homo sapiens_hsa05033 | 0.35519089 |
| 86 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.33260015 |
| 87 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.32386014 |
| 88 | GABAergic synapse_Homo sapiens_hsa04727 | 0.31952060 |
| 89 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.31427450 |
| 90 | Base excision repair_Homo sapiens_hsa03410 | 0.29413859 |
| 91 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29244197 |
| 92 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.28248810 |
| 93 | Prion diseases_Homo sapiens_hsa05020 | 0.27586208 |
| 94 | Alcoholism_Homo sapiens_hsa05034 | 0.25887099 |
| 95 | Adherens junction_Homo sapiens_hsa04520 | 0.25610927 |
| 96 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.25429431 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.24951429 |
| 98 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.24601568 |
| 99 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24299853 |
| 100 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.23676739 |
| 101 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.20938656 |
| 102 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.19910558 |
| 103 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.19066779 |
| 104 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.18994827 |
| 105 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.14769601 |
| 106 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.14087708 |
| 107 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.13719091 |
| 108 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.03983629 |
| 109 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.01418306 |
| 110 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.00484148 |
| 111 | Alzheimers disease_Homo sapiens_hsa05010 | -0.2232091 |
| 112 | Huntingtons disease_Homo sapiens_hsa05016 | -0.1994978 |
| 113 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1750148 |
| 114 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1530207 |
| 115 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1356379 |
| 116 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.1281602 |
| 117 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1124503 |
| 118 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1006905 |
| 119 | Parkinsons disease_Homo sapiens_hsa05012 | -0.0981076 |
| 120 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0638854 |
| 121 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0566944 |
| 122 | Bladder cancer_Homo sapiens_hsa05219 | -0.0508337 |
| 123 | Proteasome_Homo sapiens_hsa03050 | -0.0498722 |
| 124 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.0231454 |

